Results

In a setback, Global Blood Therapeutics scraps IPF program as lead drug flounders in proof-of-concept trials

New Products, Vaccines

GSK grabs FDA OK for new shingles vaccine, which will now tackle a key Merck franchise

Combos, FDA

FDA adds fresh ‘breakthrough’ for Novartis' cancer combo Tafinlar and Mekinist
More news caret

calendar Protocols

Quick hits from around the biopharma web

Oct 23

UK’s NICE will cover $700K cost of GSK’s gene therapy; Evoke shares spike on NDA plans

Oct 20

Big Pharma R&D is exiting China, but leaving a legacy; China's biotech execs couldn’t be happier

Oct 19

Spectrum shares spike on preliminary PhII cancer data; Clinipace names a new CEO

Oct 18

Ablynx sets up a $175M IPO; Blade bags second tranche; Gritstone inks delivery tech deal with Arbutus

More Protocols caret

DNA Deep dives

Optimizing clinical outcomes for challenging molecules with lipid-based drug delivery

What’s a biotech CEO worth? The top 15 pay packages puts a spotlight on performance — usually

A biotech billionaire tops the list of the 15 highest paid R&D execs in biopharma

The top 15 spenders in the global drug R&D business: 2017

Planning a clinical supply program? Don’t overlook primary packaging.

Alzheimer’s: Learning From a Legacy of Bitter Setbacks

twitter Marco

Hot BioTwitter bot - last updated ago

arrow-thick Most Viral

FDA Approves Soliris® (Eculizumab) for the Treatment of Patients with Generalized Myasthenia Gravis (gMG)

BusinessWire a day

Many Breast Cancer Patients Receive More Radiation Therapy Than Needed

NPR.org Liz Szabo a day

To Mend a Birth Defect, Surgeons Operate on the Patient Within the Patient

New York Times Denise Grady a day

Alexion wins OK for expanded use of its ultra-pricey drug for rare diseases

STAT a day

Harvard researchers' speculative, poop-based sports drink company raises questions about conflicts of interest

HealthNewsReview.org Andrew Holtz a day

Agenus creates New Cell Therapy subsidiary named AgenTus Therapeutics

Investors | Agenus a day

Spero Therapeutics sets terms for $75 million IPO

Renaissance Capital a day

U.S. Hospitals Wrestle With Shortages of Drug Supplies Made in Puerto Rico

New York Times Katie Thomas a day

Genetic testing of embryos is creating an ethical morass

STAT a day

The Cookie Crumbles: A Retracted Study Points to a Larger Truth

New York Times Aaron E. Carroll a day

timer Latest

STAT

Alexion wins OK for expanded use of its ultra-pricey drug for rare diseases

POLITICO Magazine

How Iowa Became An Obamacare Horror Story

FDA

FDA Taking New Steps to Better Inform Physicians about Biosimilars Through Education about these Potentially Cost-Saving Options

The New Yorker

The Family That Built an Empire of Pain

New York Times

U.S. Hospitals Wrestle With Shortages of Drug Supplies Made in Puerto Rico

GlobeNewswire News Room

Five Prime Therapeutics Announces Appointment of Aron Knickerbocker as CEO Effective January 1, 2018

BusinessWire

FDA Approves Soliris® (Eculizumab) for the Treatment of Patients with Generalized Myasthenia Gravis (gMG)

WSJ

Iowa Halts Effort to Overhaul Affordable Care Act

Forbes

Fetter Leaves Tenet Healthcare As CEO

WSJ

Iowa Halts Effort to Overhaul Affordable Care Act

fire Hot This Week

1

New York Times

F.D.A. Approves Second Gene-Altering Treatment for Cancer

2

FDA

FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma

3

BusinessWire

FDA Approves Soliris® (Eculizumab) for the Treatment of Patients with Generalized Myasthenia Gravis (gMG)

4

STAT

FDA approves a game-changing treatment for blood cancer

5

WSJ

Hacking Is a Risk for Pacemakers. So Is the Fix

6

STAT

Celgene just lost a crucial drug for its revenue stream after a clinical trial blowup

7

ENDPOINTS NEWS

Celgene's $710M deal on mongersen implodes as Phase III Crohn's study flops

8

BusinessWire

Kite’s Yescarta™ (Axicabtagene Ciloleucel) Becomes First CAR T Therapy Approved by the FDA for the Treatment of Adult Patients With Relapsed or Refractory Large B-Cell Lymphoma After Two or More Lines of Systemic Therapy

9

Forbes

Tiny Ignyta's Lung Cancer Drug Bested Pfizer's. Probably. Will We Ever Know For Sure?

10

STAT

Lawmaker, wife of Tom Price, asks about 'quarantine' of people with HIV

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
← Go back